With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Gen Z consumes the most anime, survey reveals Jul 15, 2021
- One of the survivors of the Texas massacre was saved by pretending to be dead with the blood of a companion May 26, 2022
- Ari Telch broke the silence about the alleged estrangement between his daughter and Ninel Conde May 18, 2022
- A very special Volkswagen ID.3 | FormulaPassion.it Sep 4, 2021
- The Golden Scorpion was in Ventaneando and bothered Pedrito Sola Jun 3, 2022
- One and a half million families in Evergrande real estate limbo Sep 25, 2021
- Denis Brogniart : how the containment has allowed him to achieve his dream May 8, 2020